🟢 Strong Evidence
Three of the most widely supplemented micronutrients—creatine, collagen, and magnesium—work through distinct biochemical pathways that reveal why dietary intake and supplementation are not always equivalent interventions. Research published across three decades shows that each compound’s efficacy depends less on absolute dosing than on understanding the specific molecular constraint it addresses: methyl-group demand for creatine, vitamin C availability for collagen synthesis, and neuronal channel blockade for magnesium. Yet many popular supplement formulations ignore these mechanisms, raising questions about efficacy and the role of cofactors in determining outcomes.
Key takeaways
- Creatine supplementation reduces endogenous synthesis by approximately 40% but does not necessarily spare homocysteine levels, as the body redistributes surplus methyl groups rather than simply saving them
- Collagen requires continuous vitamin C replenishment to hydroxylate proline residues and stabilise the triple helix; most efficacy studies co-administer vitamin C, but those that don’t rarely control for baseline status
- Magnesium deficiency impairs the NMDA receptor’s resting blockade mechanism, allowing neurons to fire prematurely; serum magnesium reflects less than 1% of total body stores, making standard blood tests an unreliable measure of deficiency
Methyl-group demand and magnesium physiology: two metabolic constraints
Percentage of metabolic pathways affected by creatine synthesis demand and serum-to-total magnesium ratio
Source: Brosnan et al., Amino Acids 2011; Rosanoff et al., Nutr Rev 2012 | Georgian Medical Journal News
Creatine and the methyl-group economy
The human body synthesizes approximately 2 grams of creatine daily through a two-step enzymatic pathway that begins in the kidneys and is completed in the liver. According to research published in Brosnan et al. in Amino Acids (2011), this synthesis consumes roughly 40% of all methyl groups derived from S-adenosylmethionine (SAM), the cell’s primary methylation currency. These methyl groups are essential for dozens of other cellular processes, including DNA methylation, neurotransmitter synthesis, and immune function.
When creatine is supplemented exogenously—typically at 3–5 grams per day—the body responds by downregulating AGAT (L-arginine:glycine amidinotransferase), the first enzyme in the endogenous creatine synthesis pathway. This regulatory feedback reduces the demand on the methylation system, theoretically sparing methyl groups for other uses. Human trials published by Stead et al. in the American Journal of Physiology: Endocrinology and Metabolism (2001) confirm that supplemental creatine does indeed suppress endogenous synthesis and reduce SAM consumption.
However, the downstream clinical benefit to homocysteine metabolism—a claim sometimes made in supplement marketing—remains unconfirmed. According to Peters et al. in the Journal of Nutrition (2015), the surplus methyl groups freed by reduced creatine synthesis do not accumulate; instead, the body’s metabolic system redistributes them to other pathways according to cellular demand. This means that while creatine supplementation does spare methylation capacity, it does not guarantee clinical improvements in homocysteine levels or related metabolic markers without additional dietary intervention.
Creatine supplementation reduces endogenous synthesis and SAM consumption by approximately 40%, but the body redistributes surplus methyl groups rather than simply accumulating them, meaning homocysteine benefit is not automatic.
— Brosnan et al., Memorial University of Newfoundland, and Peters et al., University of Groningen (Amino Acids and Journal of Nutrition, 2011–2015)
Collagen stability and vitamin C dependency
Collagen’s structural integrity depends on a post-translational modification that most supplement marketing overlooks entirely. After collagen polypeptides are synthesised, proline residues within the triple helix must be hydroxylated—a process that converts proline to hydroxyproline, locking the triple helix into a stable configuration. Research by Peterkofsky published in the American Journal of Clinical Nutrition (1991) established that this hydroxylation reaction absolutely requires vitamin C as a cofactor, and the ascorbate is oxidised during the reaction, meaning continuous replenishment is biochemically necessary.
Without adequate vitamin C, the collagen triple helix remains unstable. According to Shoulders & Raines in the Annual Review of Biochemistry (2009), unhydroxylated collagen denatures at approximately 24°C—well below normal body temperature of 37°C—rendering it non-functional. The implication is stark: your body is not short on collagen quantity; it is short on the post-translational modification that permits collagen to survive inside you.
Yet most published collagen supplementation studies co-administer vitamin C alongside the collagen dose. The minority of trials that do not include vitamin C rarely control for participants’ baseline vitamin C status, making it impossible to attribute efficacy to collagen alone. This methodological gap means that popular standalone collagen supplements—those without concurrent vitamin C dosing—lack robust evidence of efficacy independent of the user’s existing micronutrient status. For readers interested in understanding when supplementation is appropriate, see SheniEkimi’s explainer on micronutrient sufficiency.
Magnesium and the NMDA receptor blockade mechanism
Magnesium’s role in neuronal physiology is fundamentally different from its role in bone mineralisation or enzyme cofactor function. Landmark work by Mayer et al. published in Nature (1984) revealed that Mg²⁺ ions physically occupy and block the NMDA receptor’s ion channel at resting potential, preventing calcium influx and maintaining neuronal quiescence. This blockade is voltage-dependent: when the neuron is properly depolarised, magnesium exits the channel, allowing calcium to enter and signal propagation to proceed.
When magnesium is low, this physical blockade weakens, and neurons become hyperexcitable—firing in response to subthreshold stimuli. This explains why magnesium deficiency can present clinically as anxiety, insomnia, and sensory irritability before serum magnesium levels ever drop below the laboratory reference range. Rosanoff et al. in the Nutrition Reviews (2012) emphasised a critical diagnostic limitation: serum magnesium reflects less than 1% of total body magnesium stores, the vast majority of which is compartmentalised in intracellular and bone pools.
This means that standard blood tests are an unreliable measure of magnesium sufficiency for neuronal function. A person with a serum magnesium level within the normal range (typically 0.75–0.95 mmol/L) can still have functionally depleted intracellular magnesium and experience symptomatic neuronal hyperexcitability. Clinical assessment must therefore incorporate symptomatology and, where available, more specific markers of magnesium status. For clinical updates on neurophysiology and mineral metabolism, see GMJ News Clinical Updates.
What this means
Frequently asked questions
Why do creatine supplements not automatically lower homocysteine if they spare methyl groups?
According to Peters et al. (2015), the body’s metabolic system redistributes surplus methyl groups according to cellular demand rather than allowing them to accumulate. This redistribution is dynamic and depends on other dietary factors, folate status, and B vitamin adequacy. Homocysteine reduction requires coordinated management of multiple methyl-dependent pathways, not isolated creatine supplementation.
Can collagen supplements work without vitamin C?
No—not for new collagen synthesis. Collagen hydroxylation is an obligate vitamin C-dependent reaction (Peterkofsky, 1991). Standalone collagen supplements may deliver amino acids that support structural protein, but these do not undergo the post-translational modification necessary for functional triple-helix stability without concurrent vitamin C. If studying collagen efficacy, look for trials that explicitly co-administer vitamin C and control for baseline status.
What is the correct way to test for magnesium deficiency?
Serum magnesium testing is unreliable because serum represents less than 1% of total body stores (Rosanoff et al., 2012). Clinical assessment should prioritise symptomatology (anxiety, insomnia, muscle tension, hyperreflexia) and, where available, red blood cell magnesium or ionised magnesium testing. If symptoms of neuronal hyperexcitability are present, trial supplementation with clinical monitoring may be more informative than relying on a single serum test.
As nutrient biochemistry becomes better integrated into clinical practice, the gap between popular supplement use and evidence-based micronutrient science narrows. The three mechanisms reviewed here—creatine’s methylation economy, collagen’s vitamin C dependency, and magnesium’s NMDA blockade—exemplify why mechanism matters more than dosage alone. Future supplement formulations and clinical protocols will benefit from explicit consideration of these pathways and their cofactor requirements, moving the field toward precision nutrient intervention rather than broad-spectrum supplementation.
Source: Because Friday
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
